Improved bladder function after prophylactic treatment of the high risk neurogenic bladder in newborns with myelomeningocele

Journal of Urology

Volumn 162, Issue 3 II, 1999, Pages 1068-1071

  Kaefer, Martin ^a,b   Pabby, Ajay ^b   Kelly, Mary ^b   Darbey, Mary ^b   Bauer, Stuart B ^b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b RILEY CHILDREN S HOSPITAL   (United States)

Author keywords

Abnormalities; Anticholinergics; Bladder; Meningomyelocele

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT;

BLADDER DYSFUNCTION; CHILD; CLINICAL ARTICLE; CONFERENCE PAPER; DETRUSOR DYSSYNERGIA; FEMALE; FOLLOW UP; HUMAN; INTERMITTENT CATHETERIZATION; MALE; MENINGOMYELOCELE; NEUROGENIC BLADDER; PRIORITY JOURNAL; URODYNAMICS;

EID: 0032832038     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)68069-8     Document Type: Conference Paper

References (25)

1. Smith, E. D.: Urinary prognosis in spina bifida. J. Urol., 108: 815, 1972.
2. Bauer, S. B.: Neurogenic dysfunction of the lower urinary tract in children. In: Campbell's Urology, 7th ed. Edited by P. C. Walsh, A. B. Retik, E. D. Vaughan and A. J. Wein. Philadelphia: W. B. Saunders Co., chapt. 65, 1998.
3. Galloway, N. T. M., Mekras, J. A., Helms, M. and Webster, G. D.: An objective score to predict upper tract deterioration in myelodysplasia. J. Urol., 145: 535, 1991.
4. Ghoniem, G. M., Roach, M. B., Lewis, V. H. and Harmon, E. P.: The value of leak pressure and bladder compliance in the urodynamic evaluation of meningomyelocele patients. J. Urol., 144: 1440, 1990.
5. McGuire, E. J. and Savastano, J. A.: Urodynamic findings and long-term outcome management of patients with multiple sclerosis-induced lower urinary tract dysfunction. J. Urol., 132: 713, 1984.
6. Mandell, J., Lebowitz, R. L., Hallett, M., Khoshbin, S. and Bauer, S. B.: Urethral narrowing in region of external sphincter: radiologic-urodynamic correlations in boys with myelodysplasia. AJR, 134: 731, 1980.
7. Edelstein, R. A., Bauer, S. B., Kelly, M. D., Darbey, M. M., Peters, C. A., Atala, A., Mandell, J., Colodny, A. H. and Retik, A. B.: The long-term urological response of neonates with myelodysplasia treated proactively with intermittent catheterization and anticholinergic therapy. J. Urol., 154: 1500, 1995.
8. Bauer, S. B., Hallett, M., Khoshbin, S., Lebowitz, R. L. and Winston, K. R.: Predictive value of urodynamic evaluation in newborns with myelodysplasia. J.A.M.A., 252: 650, 1984.
9. Shapiro, E., Becich, M. J., Perlman, E. and Lepor, H.: Bladder wall abnormalities in myelodysplastic bladders: a computer assisted morphometric analysis. J. Urol., 145: 1024, 1991.
10. Kaefer, M., Zurakowski, D., Bauer, S. B., Retik, A. B. and Peters, C. A.: Estimating normal bladder capacity in children. J. Urol., 158: 2261, 1997.
11. Kaefer, M. and Bauer, S. B.: Surgical correction of incontinence in myelodysplastic children. In: Urologic Surgery in Infants and Children. Edited by Lowel King. Philadelphia: W. B. Saunders Co., 1998.
12. Teichman, J. M. H., Scherz, H. C., Kim, K. D., Cho, D. H., Packer, M. G. and Kaplan, G. W.: An alternative approach to myelodysplasia management: aggressive observation and prompt intervention. J. Urol., 152: 807, 1994.
13. Bauer, S. B., Lais, A. and Scott, R. M.: Continuous urodynamic surveillance of babies with myelodysplasia. Eur. J. Ped. Surg., 2: 35, 1992.
14. McGuire, E. J., Woodside, J. R., Borden, T. A. and Weiss, R. M.: Prognostic value of urodynamic testing in myelodysplastic patients. J. Urol., 126: 205, 1981.
15. Hoover, D. and Duckett, J. W.: Posterior urethral valves, unilateral reflux and renal dysplasia: a syndrome. J. Urol., 128: 994, 1982.
16. Kaefer, M., Keating, M., Adams, M. and Rink, R.: Posterior urethral valves, pressure pop-offs and bladder function. J. Urol., 148: 708, 1995.
17. Peters, C. A., Vasavada, S., Dator, D., Carr, M., Shapiro, E., Lepor, H., McConnell, J., Retik, A. B. and Mandell, J.: The effect of obstruction on the developing bladder. J. Urol., 148: 491, 1992.
18. Malkowicz, S., Wein, A. J., Elbadawi, A., Van Arsdalen, K., Ruggieri, M. and Levin, R.: Acute biochemical and functional alterations in the partially obstructed rabbit urinary bladder. J. Urol., 136: 1324, 1986.
19. Kaefer, M., Andler, R., Haberstroh, K., Vemulapalli, S., Retik, A. B., Freeman, M. and Bizios, R.: Physiologic levels of hydrostatic pressure result in upregulation of heparin-binding EGF like growth factor (HB-EGF) in cultured neonatal bladder smooth muscle cells. Unpublished data.
20. Raab, G. and Klagsbrun, M.: Heparin-binding EGF-like growth factor. Biochim. Biophys. Acta., 1333: F179, 1997.
21. Diokno, A. C. and Lapides, J.: Oxybutynin: a new drug with analgesic and anticholinergic properties. J. Urol., 108: 307, 1972.
22. Kaefer, M., Tobin, M. S., Hendren, W. H., Bauer, S. B. and Peters, C. A.: Continent urinary diversion: the Children's Hospital experience. J. Urol., 157: 1394, 1997.
23. Kaefer, M., Hendren, W. H., Bauer, S. B., Goldenblatt, P., Peters, C. A., Atala, A. and Retik, A. B.: Reservoir calculi: a comparison of reservoirs constructed from stomach and other enteric segments. J. Urol., 160: 2187, 1998.
24. Joseph, D. B., Bauer, S. B., Colodny, A. H., Mandell, J. and Retik, A. B.: Clean intermittent catheterization of infants with neurogenic bladder. Pediatrics, 84: 78, 1989.
25. Buyse, G., Waldeck, K., Verpoorten, C., Bjork, H., Casaer, P. and Andersson, K.: Intravesical oxybutynin for neurogenic bladder dysfunction: less systemic side effects due to reduced first pass metabolism. J. Urol., 160: 892, 1998.